Eli Lilly
Found 3 recent publications
The turnaround in the diet battle: the market leader falls behind as a rival hits a trillion-dollar valuation
Three years ago, Novo Nordisk ruled the market with an iron hand, but Eli Lilly has made a massive overtake. The pill revolution, price drops in the USA, and a lawsuit — the drama behind a market worth hundreds of billions.
Eli Lilly Expands Access to Retatrutide Weight-Loss Drug
Eli Lilly is launching an early access program for Retatrutide, a promising weight-loss drug that has shown record-breaking results in clinical trials. The move follows concerns over a black market for counterfeits.
Prof. Rafi Carasso warns: "The approach to weight-loss injections is changing"
The doctor and media personality addressed the thriving weight-loss drug industry on his 103FM radio show and presented data from a new clinical trial. Alongside the impressive results, he emphasizes the central problem: "When people stop because of side effects – it is cause for concern."